Skip to main content

Table 6 Secondary outcome measures stratified by PSH group

From: Influence of paroxysmal sympathetic hyperactivity (PSH) on the functional outcome of neurological early rehabilitation patients: a case control study

 

Total

PSH+

PSH-

p value

Number of subjects

144

72

72

 

Duration of tracheal cannula, d (Md; IQR)

34 (20–52)

35 (25–49)

27 (14–55)

.182a

Duration of ventilation, h (Md; IQR)

280 (137–521)

296 (131–519)

268 (139–667)

.947a

Successful weaning (n; %)

90 (62.5%)

45 (62.5%)

45 (62.5%)

1.000b

Secondary diagnoses, n (Md; IQR)

32 (27–36)

33 (27–35)

32 (25–37)

.792a

Duration of interruptions, d (Md; IQR)

7 (5–14)

7 (5–13)

7 (4–15)

.841a

Length of stay, d (Md; IQR)

75 (46–108)

77 (56–110)

73 (42–103)

.303a

ΔERI, points (Md; IQR)

100 (50–150)

100 (50–150)

75 (25–150)

.988a

ΔBI, points (Md; IQR)

5 (5–22.5)

5 (5–10)

5 (5–28)

.113a

  1. aMann-Whitney U test; b χ2 test. ERI = Early Rehabilitation Index; BI=Barthel Index